Priebe Waldemar
Related Filers (2)
Ownership (5)
4
Tuesday, 1/25/2022
CNS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/24/2020
Moleculin Biotech, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/8/2019
CNS Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 8/18/2017
Moleculin Biotech, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 8/8/2016
Moleculin Biotech, Inc.: Initial statement of beneficial ownership of securities